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Background: In order to avoid proliferation of microorganisms, cleaning, disinfection and sterilisation in health
centres is of utmost importance hence reducing exposure of workers to biological agents and of clients that attend
these health centres to potential infections. One of the most commonly-used chemical is glutaraldehyde. The ef-
fects of its exposure are well known in the hospital setting; however there is very little information available with
regards to the primary health care domain.
Objective: To determine and measure the exposure of health workers in Primary Health Care Centres.
Environmental to glutaraldehyde and staff concentration will be measured and compared with regulated
Occupational Exposure Limits.
Methods/Design: Observational, cross-sectional and multi-centre study. The study population will be composed of
any health professionals in contact with the chemical substance that work in the Primary Health Care Centres in the
areas of Barcelonès Nord, Maresme, and Barcelona city belonging to the Catalan Institute of Health.
Data will be collected from 1) Glutaraldhyde consumption from the previous 4 years in the health centres under
study. 2) Semi-structured interviews and key informants to gather information related to glutaraldehyde exposure.
3) Sampling of the substance in the processes considered to be high exposure.
Discussion: Although glutaraldehyde is extensively used in health centres, scientific literature only deals with
certain occupational hazards in the hospital setting.
This study attempts to take an in-depth look into the risk factors and environmental conditions that exist in the pri-
mary care workplace with exposure to glutaraldehyde.Background
Cleaning, disinfection and sterilisation are the main tools
used to avoid microorganism proliferation and therefore
infection [1]. This has been a challenge for managers as
the nosocomial infections significantly increase costs,
jeopardise the quality of care and endanger the health
and safety of patients and workers.
These processes require the use of chemicals (detergents
and disinfectants) at all times, which must be inevitably
used on certain occasions [2,3]. However, these chemicals
are not always used properly: disinfection prior to sterilisa-
tion is a common practice that conflicts with official rec-
ommendations [4]. This practice is unnecessary and only* Correspondence: agonzalezj.bnm.ics@gencat.cat
1Basic Unit of Prevention Metropolitana Nord, Catalan Health Institute, Carrer
Torrent de Can Gaio 17, 08320 El Masnou, Spain
Full list of author information is available at the end of the article
© 2013 Jara et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orcauses an increase in the economic costs and increased
exposure to such substances.
In this regard, the fact that no established structured
training has been carried out that will increase the level
of knowledge and skills of health professionals regarding
these activities is very striking. In the majority of cases,
learning is based on the informal transmission of know-
ledge, skills and attitudes from one set of professionals to
another. While protocols on cleaning, disinfection and
sterilisation are in place in many centres, its dissemination
and implementation is poor, where these are often not up-
dated and many of the workers involved in these tasks are
in fact unaware of their existence [5-8].
Glutaraldehyde is the chemical disinfectant mainly used
in primary care centres. It is a high-level disinfectant (HLD)
classified as toxic and sensitizing. The threshold limit value. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Main and secondary variables
Primary variables
Workers concentration of glutaraldehyde (mg/m3)





Professional experience (in years)
Working shift (morning, afternoon, part-time)
Process Maximum exposure to glutaraldehyde process
Weekly exposure time (in minutes)
Individual protection equipment during handling
Product type (chemical substance)
Structure Premises, hall or consultation room with glutaraldehyde
Premises size (m3)
Premises temperature °C
Premises relative humidity (%)
Premises CO2 level (ppm)
Type of ventilation (natural or artificial)
Procedure Existence of cleaning, disinfecting and sterilization
protocols (Y/N)
Existence of glutaraldehyde handling protocols (Y/N)
Training of workers (Y/N)
Kind of information provided to the workers
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American Conference Industrial Hygienists (ACGIH) for
glutaraldehyde is 0.05 ppm as a ceiling value (TLV-C), with
the following scores: sen (sensitizing substance for skin
contact or inhalation) and A4 (not classifiable as a human
carcinogen).
The potential effects that exposure may cause are well
known: the onset of asthma in exposed workers [9],
contact dermatitis [10] and/or irritating effects to the
respiratory tract and skin [11]. There is no current evi-
dence of carcinogenic activity of glutaraldehyde owing
to its exposure [12].
Those health workers exposed to glutaraldehyde are
nurses from endoscopy units and surgical theatre [13], Xray
technicians [14], odontologists [15] and lab technicians [16].
Factors that contribute to exposure of glutaraldehyde
are inadequate and unsafe working practices [17], insuf-
ficient ventilation [18], and the failure to use goggles,
protective clothing and gloves [19].
The air concentration of a chemical substance is used
to quantitatively assess the level of exposure to workers.
There is scientific evidence that shows glutaraldehyde
air concentration in the workplace, namely hospitals:
measurements in the endoscopy department showed a
mean concentration of 3,7 ± 7,4 mg/m3 [20]; in surgi-
cal theatres values above the limit of 0.05 ppm [17]; or
in the Xray services an average of 0.0018 mg/m3, levels
in the darkroom were five times over the legal limit
values [21].
We believe that the importance of this study lies in
the scarcity of scientific publications that objectively
assess the exposure of health professionals in primary
health care to glutaraldehyde. We hope the results will
provide scientific evidence that currently does not exist on
the exposure to this substance in primary care centres, in
which a major percentage of health workers work.
The main objective of this project is to assess the ex-
posure of health professionals in the Primary Health
Care sector through the measurement of glutaraldehyde
air concentration and staff concentration and to com-
pare them to permissible exposure limits (PEL).
The secondary objective is to possess information
about exposure: physical location of the sites where the
disinfectant is being handled, environmental conditions
of these areas, times of greatest exposure, and profes-
sional workers exposed.
Methods/Design
Observational, cross-sectional and multi-centric study.
The population of the study will be any health profes-
sionals in contact with the chemical substance that work
in the Primary Health Centres in the areas of Barcelonès
Nord and Maresme, and Barcelona city belonging to the
Catalán Institue of Health.The study covers six Primary Care Services (SAP
Badalona-Sant Adrià de Besòs, SAP Santa Coloma de
Gramenet, SAP Mataró- Maresme, SAP Dreta, SAP
Esquerra, SAP Litoral y SAP Muntanya), with a total of
85 health centres with more than 7,000 employees.
Out of the entire staff, only non-medical health
personnel (nurses and nursing assistants) and medical
staff (doctors and dentists) who have contact with it
(directly or indirectly) during the workday shall be con-
sidered as exposed personnel. The study population is
initially estimated to comprise 6,420 workers. The exact
number of employees who will participate in measure-
ments cannot be confirmed yet due to the fact that this
depends on the data obtained in the hygienic survey in
order to perform the sampling strategy.
Table 1 shows the primary and secondary variables to
be collected throughout the study.Data collection
The study has 3 stages with different source of information.
Phase 1. Glutaraldehyde consumption in the health
centres included in the study over the previous 4 years.
The Economy and Financial department will be in
charge of providing the information regarding quantities
acquired and volumes utilized, expressed in litres, in the
Figure 1 Activation of the substance and filling of the tray.
Figure 2 Cleaning medical material next to the tray and
dipping it into the glutaraldehyde tray.
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workers will be established from these results.
Phase 2. Semi-structured interviews and key informants
(management teams and professionals who handle the
product) to gather information related to glutaraldehyde
exposure. A Hygienic Survey is the industrial hygiene pro-
cedure which aims to obtain all the information needed to
make a judgment on issues related to chemical exposure.
This process has the objective of collecting data not only
related to the product but also to the following aspects:
substance inventory, process flow chart, exposed worker
position and professional categories, exposure time, rooms
where glutaraldehyde is present, environmental condi-
tions where the product is used, worker information on
the kind of products they use, product safety cards,
safety measures to handle the product and workers
training. This information will lead to the strategy of
sampling the product.
Phase 3. Sampling of the substance in the environment
and in the staff that will provide the study variables. The
initial estimate is the performance of about 178 hygenic
determinations.
Measurement strategy to determine glutaraldehyde
The sampling strategy for personal and environmental
assessments will take into account all areas where there
is a potential contaminant source.
Samples will be taken from all rooms where glutaralde-
hyde is handled: odontology consultation rooms, medical
material cleaning rooms, emergency boxes, sterilisation
room.
The timeframe is determined by the moment when the
substance is at maximum exposure, such as:
 The time taken to activate the substance and fill the
tray (Figure 1).
 The time taken to clean medical material next to the
tray and dip it into the glutaraldehyde tray
(Figure 2).
 The time taken to empty the glutaraldehyde from
the tray and clean the tray (Figure 3).
 The time taken to clean and disinfect surfaces
(Figure 4).
The measurements of the staff will take 15 minutes
and 60 minutes for the environment.
The workers with higher levels of exposure to glutaral-
dehyde will be attached to an aspiration pump that will
determine their exposure level.
Operational procedure to determine exposure level
Sampling and analysis will be performed by the Instituto
Nacional de Seguridad e Higiene en el Trabajo (INSHT):
“Glurataldehyde determination in the air throughadsorption method using silica gel coated with 2,4
dinitrophenylhydrazine and High Performance Liquid
Chromatography with UV detection” is an active sam-
pling by solid adsorbent (silica gel).
Before and after each measurement, the pump will be
calibrated through the primary airflow meter DryCal®
DC_Lite Bios obtaining ten readings for previous and 10
for subsequent flows for each measurement. To calculate
the concentration, average flow will be used.
To transport and preserve the samples for the purpose
of avoiding contamination, they will be kept inside a small
box in a fridge. A control tube (white) will be inserted for
each batch.
To determine the exposure levels, the collection equip-
ment will be first attached to the exposed professional for
15 minutes. Afterwards, several collection devices will be
placed near the contamination focus for a minimum of
60 minutes.
Figure 3 Emptying the glutaraldehyde from the tray and
cleaning it.
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data will be collected: air temperature, relative humidity,
CO2 levels, room area, room air renovation, data regard-
ing handling of the chemical substance and the number
of exposed workers.
Measurement instruments and Material:
 Four low flow sampling pumps SKC®, model
Universal DE Luxe, Eex ia IIC T4.
 Silica gel SKC Ref. 226–119 (silica gel coated with
2.4 DNPH).
 Primary calibrator DryCal® DC-Lite Bios, model
DCL-M.
 Therrmo-hygrometer model TES 1360.
 Ambient CO2 level meter TESTO 535.
Additional material: measurement instruments, silicone
tubs (1.2 cm in external diameter and 0.6 in internal) and
teflon.Figure 4 Cleaning and disinfecting surfaces.Analysis
Microsoft Office Access and Stata version 11 will be
used to manage the data. Once the data have been en-
tered, the quality of the data will be evaluated, treating
extreme, incongruent and rare values.
For the main objective, there will be a descriptive ana-
lysis of the global concentration of glutaraldehyde both
in the environment and in the staff and this will be com-
pared with legal limits.
For the secondary objectives, a descriptive analysis will
be performed of the product concentration stratified by
room, employment position, professional categories and
for tasks identified for maximum exposure. The associ-
ation of glutaraldehyde concentration and CO2 levels,
temperature, relative humidity, ventilation and room
area will also be studied. For the association of quantita-
tive variables, the Pearson correlation coefficient will be
used and for qualitative variables, Student’s t-test will be
used. All statistical tests will have a confidence interval
of 95%.
Discussion
The use of chemical substances during cleaning, disinfec-
tion and sterilisation are unavoidable: detergents to clean,
disinfectants for term-sensitive materials and equipment
and working surfaces, and high performance disinfectants
to sterilise medical material [7,22]. The excellent proper-
ties of glutaraldehyde makes it the first choice in health
centres in terms of considerations for health and safety in
the workplace. Many papers illustrated and described the
hazards of glutaraldehyde to the exposed health workers
in the hospital environment [17,18]. However there is very
little evidence in the primary care setting even though it is
more utilized by the population.
The lack of studies on the use and exposure to these
types of substances of workers in primary health care is
paradoxical when, in a health district such as ours, the
proportion of health workers in primary care settings dou-
bles the number of workers in hospital care. This situation
highlights that there may be large groups of workers likely
to be subjected to unstudied exposures, also generating
situations of inequality in terms of hygiene and safety in
the workplace for workers in the same group.
This study intends to evidence the utilization of glutar-
aldehyde in the primary health care centres and the haz-
ard exposure to its health workers. At the same time, it
aims to provide evidence or data to help us to find out
more accurately aspects related to exposure to the chem-
ical disinfectant in the primary care setting.
One limitation of the study lies in the knowledge of
the population susceptible to exposure in order to better
define the sampling strategy. For this reason, the starting
point is those workers who by virtue of their roles may
be exposed at some point in their work (nurses, doctors
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ganisation of primary care, this ratio is high in our case
(about 90%), and we consequently expect that surveys
performed in Phase 2 of the study will help establish bet-
ter the population susceptible to exposure.
The sampling strategy established in this study involves
making staff and environmental hygienic determinations
at all possible periods identified a priori as maximum ex-
posure and at all areas where there are trays with the
substance (an estimation of 178 determinations). The full
sample periods which presumably give the most unfavour-
able conditions minimises the constraints imposed by hav-
ing to randomly select 15-minute periods out of the entire
workday, even if this means carrying out a large number
of measurements.
The probability of exceeding the TLV-C value in any
of the periods not sampled will need to be subsequently
calculated based on the results.
The results of this study will lead to a revision of the
cleaning, disinfecting and sterilisation processes and proto-
cols in primary health care [2,3,5]. Moreover, information
about these processes of handling hazardous substances,
use of security cards, existence and implementation of pro-
tocols and use of protective equipment will be provided by
the study.
Other studies have shown the need to deepen the
awareness of primary care professionals in order to pos-
sess knowledge and to adopt evidence-based practices
and standard operating procedures or practice guidelines
[23,24]. In this sense, we believe that the results of the
study may be useful for those systems with a decentra-
lised primary care network in their hospital system. We
believe that the data provided by the study can be gener-
alised in such health systems, particularly in relation to
defining job posts and the group of primary health care
workers likely to be exposed to these substances.
In short, the situation analysis will allow to compare
diferent health centres and to propose improvements to
protective measures or, eventually, to propose another
less harmful chemical instead of gluraldehyde. If glutaral-
dehyde can not be replaced, preventive actions to reduce
exposure to vapors of this substance will be proposed.
It is therefore necessary to establish safe environment
workplaces wherever glutaraldehyde is used [25]. Pre-
cautions to be taken during handling in order to avoid
breathing in vapours are as follows: the introduction of
automatic washing machines [5] has been proposed; that
it must not be used in the form of a spray or aerosol;
that it is not handled or emptied in the presence of flam-
mable vapour; that goggles, protective clothing and gloves
are worn; that everyone washes thoroughly with soap and
water after handling, that contaminated clothing are re-
moved and washed before reuse, that containers are kept
closed and that adequate ventilation is used [26]. Trainingand information to the exposed workers also reduces the
exposure to glutaraldehyde [27]. On the other hand, the
results of the study will serve as a starting point for asses-
sing the effectiveness of interventions that may be imple-
mented in order to reduce exposures that may endanger
the health of workers [28].
While it is not the aim of the study to identify and de-
scribe the health effects of the exposed health workers,
it will provide the knowledge about the number of
primary healthcare workers at risk and their profes-
sional category that may allow to plan future protective
measures and perhaps to investigate low concentration
chronic exposure.
The project is currently at the end of the field work
and data collection stage. Preliminary results will be
available in a few months.
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